List of Excipients in API ELINZANETANT
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ELINZANETANT
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | LYNKUET | elinzanetant | 50419-475 | .ALPHA.-TOCOPHEROL | |
| Bayer HealthCare Pharmaceuticals Inc | LYNKUET | elinzanetant | 50419-475 | CAPRYLOCAPROYL POLYOXYLGLYCERIDES | |
| Bayer HealthCare Pharmaceuticals Inc | LYNKUET | elinzanetant | 50419-475 | FERRIC OXIDE RED | |
| Bayer HealthCare Pharmaceuticals Inc | LYNKUET | elinzanetant | 50419-475 | FERRIC OXIDE YELLOW | |
| Bayer HealthCare Pharmaceuticals Inc | LYNKUET | elinzanetant | 50419-475 | GELATIN | |
| Bayer HealthCare Pharmaceuticals Inc | LYNKUET | elinzanetant | 50419-475 | GLYCERIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for ELINZANETANT
Excipient focus: .ALPHA.-TOCOPHEROL
ELINZANETANT drug variants containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | elinzanetant | 50419-475 |
| >Company | >Ingredient | >NDC |
ELINZANETANT drug variants not containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CAPRYLOCAPROYL POLYOXYLGLYCERIDES
ELINZANETANT drug variants containing CAPRYLOCAPROYL POLYOXYLGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | elinzanetant | 50419-475 |
| >Company | >Ingredient | >NDC |
ELINZANETANT drug variants not containing CAPRYLOCAPROYL POLYOXYLGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
ELINZANETANT drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | elinzanetant | 50419-475 |
| >Company | >Ingredient | >NDC |
ELINZANETANT drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
ELINZANETANT drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | elinzanetant | 50419-475 |
| >Company | >Ingredient | >NDC |
ELINZANETANT drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
ELINZANETANT drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | elinzanetant | 50419-475 |
| >Company | >Ingredient | >NDC |
ELINZANETANT drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
ELINZANETANT drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | elinzanetant | 50419-475 |
| >Company | >Ingredient | >NDC |
ELINZANETANT drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE
ELINZANETANT drug variants containing GLYCERYL MONOCAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | elinzanetant | 50419-475 |
| >Company | >Ingredient | >NDC |
ELINZANETANT drug variants not containing GLYCERYL MONOCAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOOLEATE
ELINZANETANT drug variants containing GLYCERYL MONOOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | elinzanetant | 50419-475 |
| >Company | >Ingredient | >NDC |
ELINZANETANT drug variants not containing GLYCERYL MONOOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
ELINZANETANT drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | elinzanetant | 50419-475 |
| >Company | >Ingredient | >NDC |
ELINZANETANT drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
ELINZANETANT drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | elinzanetant | 50419-475 |
| >Company | >Ingredient | >NDC |
ELINZANETANT drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM
ELINZANETANT drug variants containing TITANIUM
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | elinzanetant | 50419-475 |
| >Company | >Ingredient | >NDC |
ELINZANETANT drug variants not containing TITANIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch